Stereotactic ablative radiotherapy in patients with early-stage non-small cell lung cancer and co-existing interstitial lung disease

被引:11
|
作者
Finazzi, Tobias [1 ]
Ronden-Kianoush, Merle I. [1 ]
Spoelstra, Femke O. B. [1 ]
Nossent, Esther J. [2 ]
Nijman, Suzan F. M. [2 ]
Bahce, Idris [2 ]
Dickhoff, Chris [3 ]
Senan, Suresh [1 ]
机构
[1] Univ Amsterdam, Dept Radiat Oncol, Med Ctr, Amsterdam, Netherlands
[2] Univ Amsterdam, Dept Pulm Med, Med Ctr, Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Surg & Cardiothorac Surg, Med Ctr, Amsterdam, Netherlands
关键词
IDIOPATHIC PULMONARY-FIBROSIS; RADIATION-THERAPY; PNEUMONITIS; PIRFENIDONE; SURVIVAL; TUMORS; SABR;
D O I
10.1080/0284186X.2020.1730002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:569 / 573
页数:5
相关论文
共 50 条
  • [41] Stereotactic Ablative Radiotherapy (SABR) for Non-Small Cell Lung Cancer
    Iyengar, Puneeth
    Westover, Kenneth
    Timmerman, Robert D.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (06) : 845 - 854
  • [42] Stereotactic Ablative Radiotherapy in the Management of Synchronous Early Stage Non-Small Cell Lung Cancers
    Ayoub, Z.
    Brooks, E.
    Welsh, J.
    Chen, A.
    Gandhi, S.
    Heymach, J.
    Vaporciyan, A.
    Chang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S272 - S272
  • [43] Defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high-risk, early-stage non-small cell lung cancer
    Louie, Alexander V.
    Siva, Shankar
    Senan, Suresh
    CANCER, 2016, 122 (02) : 322 - 323
  • [44] Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early-stage non-small cell lung cancer
    Zekai Shu
    Baiqiang Dong
    Lei Shi
    Wei Shen
    Qingqing Hang
    Jin Wang
    Yuanyuan Chen
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 1263 - 1271
  • [45] Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early-stage non-small cell lung cancer
    Shu, Zekai
    Dong, Baiqiang
    Shi, Lei
    Shen, Wei
    Hang, Qingqing
    Wang, Jin
    Chen, Yuanyuan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (05) : 1263 - 1271
  • [46] Stereotactic body radiotherapy for early stage non-small cell lung cancer
    Lagerwaard, F.
    LUNG CANCER, 2012, 77 : S9 - S10
  • [47] To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer
    Shultz, David Benjamin
    Diehn, Maximilian
    Loo, Billy W., Jr.
    SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (02) : 78 - 86
  • [48] Nivolumab After Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Randomized I-SABR Trial
    Chang, J. Y.
    Lin, S. H.
    Dong, W.
    Liao, Z.
    Gandhi, S.
    Chun, S. G.
    Gay, C. M.
    Zhang, J.
    Fossella, F. V.
    Blumenschein, G. R.
    Cascone, T.
    Le, X.
    Pozadzides, J. V.
    Tsao, A.
    Mehmet, A.
    Welsh, J. W.
    Verma, V.
    Wistuba, I. I.
    Lee, J.
    Heymach, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S71 - S71
  • [49] Impact of Facility Treatment Volume on Stereotactic Ablative Radiotherapy (SABR) Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC)
    Marar, M.
    Bryant, A. K.
    Nalawade, V.
    Das, M.
    Loo, B. W., Jr.
    Diehn, M.
    Chin, A. L.
    Murphy, J. D.
    Vitzthum, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E447 - E447
  • [50] Selection of patients for stereotactic lung radiotherapy (SBRT) for early stage non-small cell lung cancer (NSCLC)
    Pearson, S.
    Franks, K.
    Pearson, S.
    Purdie, T.
    Bissonnette, JI-P.
    Cho, J.
    Sun, A.
    Kane, G.
    Payne, D.
    Bezjak, A.
    RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S51 - S52